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аннотация
дендритные клетки (дК) – это специализированная группа антиген-презентирующих клеток с высокой 
функциональной пластичностью, которые проявляют иммуностимулирующий или иммуносупрессивный 
потенциал в зависимости от последовательности и комбинации стимулов микроокружения, опреде-
ляющих их дифференцировку, созревание, активацию. Разработка противоопухолевых дК-вакцин 
основана на способности дК специфически активированных in vitro мигрировать для презентации 
антигенов Т-лимфоцитам in vivo. В работе проведено изучение элементов опухолевого микроокруже-
ния, способных оказывать влияние на миграцию дК. Изучение подвижности дК в экспериментальной 
аналитической системе Cell-IQ показало наличие обратной корреляции высокой силы между сред-
ней скоростью прохождения траектории дК и содержанием иммуносупрессивных факторов (ИСФ) в 
супернатантах культивируемых клеток меланомы кожи (TGFβ1, IL-10, IL-18, VEGF-A, EGF, FGF, HGF, 
sFASL (p<0,01)). Была выявлена обратная зависимость высокой силы угла движения популяции дК от 
экспрессии раково-тестикулярных антигенов (РТА) и других опухолеассоциированных антигенов (ОАА) 
на опухолевых клетках: Melan A, тирозиназы, семейств MAGE, BAGE, NY-ESo-1 (p<0,05). Скорость 
движения дК в системе ко-культивирования с клетками меланомы №894 составила 30,10±2,23 мкм/ч и 
отличалась от таковой в присутствии 1 нг/мл IL-10 (10,45±0,52 мкм/ч), 10 нг/мл TGFβ1 (14,32±0,42 мкм/ч), 
50 нг/мл VEGF (18,7±1,89 мкм/ч) (p<0,05). Можно предполагать, что содержание этих ИСФ в перифе-
рической крови больных является одним из факторов, определяющих клиническую эффективность 
противоопухолевой дК-иммунотерапии.
Ключевые слова: дендритные клетки, миграция, иммуносупрессивные факторы, 
раково-тестикулярные антигены, Cell-IQ.
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Abstract
dendritic cells (dCs) belong to specialized pool of antigen-presenting cells with high functional plasticity and 
manifest with immunostimulatory or immunosuppressive potential depending on sequence and combina-
tion of microenvironment stimuli, which determine their differentiation, maturation and activation. The use 
of antitumor dCs vaccines is based on the ability of dCs specifically activated in vitro migrate for antigen 
presentation to T-lymphocytes. We studied the components of the tumor microenvironment that are capable 
of inhibiting dCs migration. The study of the mobility of dCs in Cell-IQ experimental analytical system showed 
the presence of an inverse correlation of high strength between the average trajectory speed and the level 
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of immunosuppressive factors (ISFs) in supernatants of cultured skin melanoma cells (TGFβ1, IL-10, IL-18, 
VEGF-A, EGF, FGF, HGF, sFASL (p<0.01). An inverse relation of high force was found between the movement 
angle of the dCs population and the expression of cancer testis antigens (CTAs) and other tumor-associated 
antigens (TAAs) on tumor cells (Melan A, tyrosinase, families of MAGE, BAGE, NY-ESo-1 (p<0.01)). The 
speed of dCs movement in culture system with melanoma cells #894 was 30.10±2.23 µm/h and differed 
from that in the presence of IL-10 1 ng/ml (10.45±0.52 µm/h), TGFβ1 10 ng/ml (14.32±0.42 µm/h), VEGF 50 
ng/ml (18.7±1.89 µm/h) (p<0.05). one can assume that content of this ISFs in the blood is one of the factors 
determining clinical efficacy of dCs immune therapy.
Keywords: dendritic cells, migration, immunosuppressive factors, cancer testis antigens, Cell-IQ.
Introduction
Tumor cells are capable of synthetizing and pro-
ducing a range of factors with inhibitory effect on the 
activity of immune cells, among which the effect on 
dendritic cells (DCs) system is particularly important. 
Cellular organisation of tumor microenvironment rep-
resents sophisticated living system with a complex of 
different stimuli, which influence all aspects of DCs 
biology and thus manage their functionality and vital-
ity [1-3]. DCs belong to specialized pool of antigen-
presenting cells with high functional plasticity and 
manifest with immunostimulatory or immunosuppres-
sive potential depending on sequence and combination 
of microenvironment stimuli, which determine their 
differentiation, maturation, activation and polarisation. 
Immature or maturating DCs are found in different 
nonlymphoid tissues and organs but after activation 
they migrate towards lymphoid tissues to interact with 
T-lymphocytes and induce immune response [4]. A low 
level expression of the MHC antigens and costimula-
tory molecules is typical for the immature DCs. They 
are not capable to efficiently activate T-lymphocytes 
still they have ability for high degree endocytosis [5-7]. 
Activation of DCs under the influence of different 
stimuli of maturation is associated with the develop-
ment of increased expression of a variety of intracellu-
lar and surface molecules providing migration of DCs 
to secondary lymphoid tissues and interaction with 
T-lymphocytes. However, activation and maturation 
of DCs are dependent on microenvironment and could 
be blocked by specific factors or their combinations 
leading to the formation of subpopulations of DCs with 
tolerogenic and immunosuppressive activity [8].
Experimental studies by K.M. Hargadon et al. 
(2016) on the model of murine melanoma have 
shown the influence of factors produced by malignant 
melanocytes on the maturation and subsequent activa-
tion of differentiated DCs from spleen and lungs [1]. 
A number of researchers have established facts of 
disturbed biophysical properties of DCs in particular 
ability to change shape of the cell under the influence 
of immunosuppressive molecules expressed by a 
tumor, such as interleukin 10 (IL-10), transforming 
growth factor (TGFβ1), vascular endothelial growth 
factor (VEGF) [9-11].
The use of antitumor dendritic cell vaccines is very 
relevant as it is based on the ability of the DCs, specifi-
cally activated in vitro, to migrate to T-lymphocytes for 
antigen presentation, therefore, the study of the tumor 
microenvironment components forming systemic and 
local immunosuppression in the patient’s body is able 
to modify properties of the DCs, thus reducing clinical 
efficacy of immunotherapy.
Materials and methods
The study was done with immature DCs (iDCs) ob-
tained from monocytes of peripheral blood samples of 
patients with skin melanoma and with skin melanoma 
cells obtained from surgical material of patients treated 
in NMRC of oncology named after N.N. Petrov from 
2001 to 2017 years. Skin melanoma cells were main-
tained as cell lines after 20 or more passages, part of 
which was deposited in the Collection of cell cultures 
of the Institute of cytology of Russian Academy of 
Sciences, Saint-Petersburg, Russia.
Differentiation of DCs from the adhesion mono-
cyte fraction from peripheral blood mononuclear 
cells of a patient with skin melanoma was carried out 
according to a standard procedure developed in the 
NMRC of oncology named after N.N. Petrov [12], 
in adhesive culture flasks (Sarstedt, Germany) under 
conditions of СО
2
 incubator «Heracel» (Termo Elec-
tron LTD GmbH, Germany) at 37°С, 5 % CO
2 
and 
98 % humidity with culture medium «Cell-Gro DC», 
granulocyte-macrophage growth factor GM-CSF (72 
ng/ml), interleukin 4 IL-4 (15 ng/ml) (CellGenix, 
Germany), which were introduced on the 1st, 3rd and 
5th day of cultivation (iDCs). On the 7th day, DCs 
were removed with 0.25% trypsin solution and BD 
Falcon Cell Scrapers (BD Biosciences, USA) and 
analysed on a flow cytometer and DCs with CD14-
CD1a+CD83-CD11c+CD86±HLA-DR+CD80±CD209+ 
immunophenotype on 92% of the DCs were used for 
the experiment.
Skin melanoma cell lines. After mechanical 
disaggregation of tumor samples, the isolated cells 
were plated in plastic flasks (Sarstedt, Germany) and 
placed into СО
2
-incubator «Heracel» (Termo Electron 
LTDGmbH, Germany), continuously cultured and re-
seeded by the method of Frechney [13], DMEM/F12 
culture medium was used (Biolot, Russia) containing 
20% bovine embryo serum (Biolot, Russia), insulin, 
transferrin, selenium, penicillin and streptomycin 
(Invitrogen, USA). When the monolayer was reached 
at different passages, the cells were removed using a 
Trypsin-Versene solution (Biolot, Russia) and used for 
the experiments. Cell lines were cultivated continu-
ously for 20 or more passages.
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Cultivation in the Cell-IQ system. The cultures of 
the iDCs and skin melanoma cells were seeded into 
two well silicone inserts (Ibidi GmbH, Germany) at 
concentration 3 х 105 cell/ml in 70 mcl of culture 
medium containing 72 ng/ml GM-CSF, 15 ng/ml 
IL-4 and tumor necrosis factor TNFα (20 ng/ml) (BD 
Biosciences, USA). After the cells were attached to 
the substrate, the inserts were removed and the plates 
were placed in analytical cell analyser system Cell-IQ 
(Chip-Man Technologies Ltd, Finland) and observed 
by the phase contrast method for 22-47 hours. The 
distance between the cell populations was 500 μm. 
To quantify the migration of the DCs we created a 
special protocol based on the library of different types 
of cellular images, which was used for qualitative and 
quantitative analysis of images of moving cells in 
real time. For the cellular modelling allogeneic cells 
having a similar immunophenotype by HLA class I: 
HLA A2 were used.
Quantitative assessment of the production of im-
munosuppressive factors (ISFs). Quantitative content 
of ISFs (IL-6, 8, 10, 18, TGFβ
1
, VEGF, follistatin, 
angiopoietin, placental growth factor PLGF, epider-
mal growth factor (EGF), stem cell growth factor 
(SFC), heparin-binding EGF-like growth factor (HB-
EGF), insulin like growth factor binding protein 1 
(IGFBP1), urokinase plasminogen activator inhibitor 
PAI-1, urokinase plasminogen activator uPA, fibrob-
last growth factor (FGF), hepatocyte growth factor 
(HGF), leptin, osteoponin, prolactin, CD95 receptor 
ligand sFASL) were determined in supernatants of 
cultured skin melanoma cells by an sandwich enzyme 
Figure. 1. Analysis of trajectory 
images of immature dCs move-
ments in the presence of skin 
melanoma cells line #894. 
A – start of dCs movement fixa-
tion and B – end of dCs move-
ment fixation under standard 
conditions of cultivation; 
C - start of dCs movement fixa-
tion and d - end of dCs move-
ment fixation in the presence of 
TGFβ1 (10 ng/ml); 
E - start of dCs movement fixa-
tion and F - end of dCs move-
ment fixation in the presence of 
IL-10 (1 ng/ml); G - start of dCs 
movement fixation and H - end 
of dCs movement fixation in the 
presence of VEGF (50 ng/ml). 
observation time 47 hours
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immunoassay and multiplex analysis on the instrument 
Bio-Plex 200 System (BIO-RAD, USA). The kits from 
«BenderMedSystems» (Germany) and «BIO-RAD» 
(USA) were used.
Quantification of expression of tumor-associated 
antigens (TAAs). Cultured skin melanoma cells were 
analysed for the presence of differentiating TAAs 
(MelanA, tyrosinase, MITF, S100, gp100) and cancer 
testis antigens (CTAs) (NY-ESO-1, families MAGE, 
BAGE, GAGE) by the flow cytometry using FAC-
SCanto II cytometer system (BD, USA) with BD 
Bioscience and Santa Cruz biotechnology reagents 
(USA).
Statistical data treatment. IBM SPSS 19.0 and Mi-
crosoft Excel 2010 software packages and the methods 
of descriptive and nonparametric statistics were used 
for the analysis [14]. Quantitative data are presented 
as mean with standard deviation (M±SD).
Results
To study the features of the motility of maturing 
DCs under the influence of products synthesized 
by melanoma cells, an in vitro system was created 
which allowed us to co-culture iDCs with human skin 
melanoma cell lines (n=8) and to evaluate speed, tra-
jectory and direction of the DCs movement. At least 
10 DCs were fixed in each view field and observed 
afterwards. The pattern of the movement of the DCs 
was determined by the distance passed by them during 
the observation period, the trajectory length, the speed 
of the trajectory pass in the selected period of time, and 
the angle of movement of the cell population, which 
determines the general direction of movement of the 
DCs (Table 1).
We observed great variability in all parameters: the 
average speed of trajectory pass was minimal when 
co-cultured with culture #311 (16.1±1.05 µm/h) and 
maximal in the presence of culture #226 (88.3±1.79 
µm/h). Angle of movement of the DCs population 
that was co-cultured with melanoma cells #226 was 
Table 1
Parameters of movement trajectories of immature DCs co-cultivated with skin melanoma cells obtained 
from different patients 
Cellular system:
co-culture 
of immature 
DCs and skin 
melanoma cells 
line #
Observation 
time (h)
Number of 
view fields 
(n)
Average 
number of 
tested cells
Distance 
passed (µm)
Trajectory 
length (µm)
Average speed 
of trajectory 
pass (µm/h)
Angle of cell 
population 
movement (°)
226 24 10 13 213.5±6.67 2094.2±15.43 88.3±1.79 51.6±3.45
283 22 8 10 102.5±4.32 398.4±12.33 17.4±1.98 340.2±9.41
311 24 9 15 94.9±9.49 374.9±19.20 16.1±1.05 343.6±3.35
643 24 10 15 132.9±5.43 1121.2±74.73 41.4±1.69 130.6±10.72
685 34 10 12 155.0±8.92 1481.0±24.78 48.6±4.70 144.0±5.23
686 34 8 20 241.0±14.34 2556.0±56.11 75.26±1.65 135.7±2.25
694 26 8 15 168.0±18.0 1345.2±39.59 52.4±1.63 333.6±8.54
894 22 10 12 291.8±31.07 1423.3±105.21 30.1±2.23 324.5±18.30
the smallest and amounted to 51.6±3.45, while in the 
presence of melanoma cells #311 this parameter was 
defined as 343.6±3.35. In order to identify the fac-
tors that have the greatest impact on DCs migration 
we analysed the dependence of the average speed of 
DCs from the ISFs found in supernatants of cell lines 
under study. High strength inverse correlation was 
revealed between this parameter of the DCs motility 
and with the amount of ISFs in the supernatants of 
skin melanoma lines, namely for TGFβ
1
, IL-10, IL18, 
VEGF-A, EGF, FGF, HGF, sFASL (p<0.01) (Table 2). 
Under the influence of the ISFs, not only the speed of 
the DCs movement changed, but also the character 
of the movement, which became more chaotic and 
multidirectional. To test the hypothesis of a possible 
dependence of the direction of DCs movement from 
the level of expression of differentiating TAAs and 
CTAs by tumor cells, a correlation analysis was car-
ried out, which revealed inverse correlation of high 
strength of angle of movement of the DCs popula-
tion from the expression of antigens, such as Melan 
A, tyrosinase, families MAGE, BAGE, NY-ESO-1 
(p<0.05) (Table 3).
To reveal more fully the nature of the effect of 
individual ISFs synthesized by the tumor on the mo-
tility of the DCs, additional defined concentrations of 
the IL-10 (1 ng/ml), TGFβ1 (10 ng/ml), VEGF-A (50 
ng/ml) were added. Table 4 represents the results of 
the analysis of the movements of the DCs in differ-
ent conditions in the system of co-cultivation with a 
culture of skin melanoma #894. The greatest impact 
was possessed by IL-10, in the presence of which the 
average speed of DCs movement decreased almost 
threefold (from 30.10±2.23 to 10.45±0.52 µm/h). Also 
in the presence of the ISFs, the distance between the 
beginning and the end of the movement observation 
and also the length of the trajectory passed decreased 
significantly, but no effect on the angle of movement 
of the cell population was detected, since statistically 
significant difference for this parameter was not found 
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Table 2
Dependence of the average speed of DCs movement on the production of immunosuppressive factors          
by cultured skin melanoma cells
Cell line 
#
TGFβ
1
 
(ng/ml)
IL-10 
(pg/ml)
VEGF-A 
(ng/ml)
IL6 
(pg/ml)
IL8 
(ng/ml)
Fol-
listatin 
(ng/ml)
IL18 
(pg/ml)
PLGF 
(pg/ml)
Angiopo-
etin 
(pg/ml)
EGF 
(pg/ml)
SCF 
(pg/ml)
226 0.73 1.53 0.79 0 0.37 0.24 0.12 116.90 0 0.43 5.02
283 23.15 48.15 5.59 8.04 0.94 2.09 25.49 632.41 538.89 419.56 2.65
311 19.84 40.70 10.05 17233.50 0.92 3.85 14.15 242.98 683.42 358.38 64.70
643 5.42 16.06 3.60 29.56 20.28 36.39 0.87 263.21 541.99 9.7 18.40
686 3.89 1.51 0.84 32.48 0.84 17.38 0.27 5266.42 12367.14 22.26 24.19
694 3.00 10.08 4.55 109.02 11.70 0.49 1.35 278.78 4999.91 191.00 22.32
685 2.43 36.67 12.70 89.86 11.01 5.17 1.29 46.53 16097.05 2.11 9.63
894 4.57 12.25 1.50 4.45 23.07 0.11 3.64 310.30 5943.86 134.00 11.87
Spear-
man 
correla-
tion, r
-0.857 -0.857 -0.833 -0.262 -0.381 -0.143 -0.881 -0.095 -0.429 -0.714 -0.095
p 0.01 0.007 0.037 0.531 0.352 0.736 0.004 0.823 0.289 0.047 0.823
Cell line 
#
Endoglin 
(pg/ml)
HB-EGF 
(pg/ml)
IGFPB-1 
(pg/ml)
PAI-1 
(pg/ml)
uPA 
(pg/ml)
FGF 
(pg/ml)
HGF 
(pg/ml)
Leptin 
(pg/ml)
Osteoponin 
(ng/ml)
Prolactin 
(pg/ml)
sFASL 
(pg/ml)
226 0 0 0 39.16 0 40 52.05 34.17 0.47 15.75 0
283 3.00 0 18.30 4228.8 0.13 84.52 118.85 16.64 18.99 24.91 221.5
311 8.50 0 5.80 66.11 0 138.62 1353.74 296.95 17.22 393.69 368.93
643 10.70 262.56 0 1606.96 0 112.62 506.36 55.00 0.38 4.33 0
686 198.42 135.61 62.82 7096.80 54.42 60.75 38.44 104.97 1.82 59.36 3.5
694 17.27 214.45 4.34 4469.30 0 42.47 38.19 24.70 14.24 13.00 4.34
685 15.68 79.20 16.39 5187.17 5.41 26.8 13.48 30.66 3.95 26.28 3.54
894 50.29 20.62 4627.00 5206.00 9433.00 91.52 73.35 21.65 1.13 0 63.29
Spear-
man 
correla-
tion, r
0.167 0.317 -0.287 0.119 -0.038 -0.738 -0.690 0.119 -0.500 -0.095 -0.790
p 0.693 0.444 0.49 0.779 0.929 0.037 0.05 0.779 0.207 0.823 0.02
Table 3
Dependence of the DCs direction of movement from TAAs expression by cultured skin melanoma cells         
(% cells)
Cell line # melanA Tyros S100 Gp100 MITF MAGE BAGE GAGE NY-ESO-1
226 49.6 97.6 68.7 99.6 21.7 89.7 94.8 99.4 79.1
283 2.5 8.7 1.2 12.6 0 0.6 0.4 1.4 6.3
311 0 28.0 5.2 87.6 49.5 18.1 4.4 92.2 11.1
643 76.8 66.6 1.0 94.1 66.5 60.5 74.5 95.8 61.7
685 40.4 75.6 0 61.6 40.2 30.3 52.5 8.8 47.9
686 11.9 60.9 3.1 77.2 73.1 18.2 24.5 48.6 67.8
694 23.0 0 59.3 90.6 5.9 0 6.8 13.8 0
894 0.7 0 5.8 99.9 0 0 0 7.6 0
Spearman 
correlation, r
-0.810 -0.707 -0.024 -0.405 -0.383 -0.755 -0.810 -0.571 -0.755
p 0.015 0.050 0.955 0.320 0.349 0.031 0.015 0.139 0.031
under the influence of the studied ISFs (Table 4, 
Figures 1, 2). Nevertheless, the method of centring 
the trajectories of the DCs allowed us to determine 
more precisely the direction of movement of the DC 
populations and to reveal certain regularities: DCs in 
control samples migrated predominantly towards the 
skin melanoma cell population, while in the presence 
of TGFβ1 and VEGF-A, trajectories of the DCs were 
shortened, but the general direction was preserved 
(Figures 2, 3). Under the influence of IL-10, the dis-
tance passed by the DCs was minimal and the relative 
distribution of cells along the length of the trajectory 
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Table 4
Parameters of trajectories of movement of immature DCs, co-cultivated with skin melanoma cells line 
#894, evaluated in different conditions
Cellular 
system
Observation 
time (h)
Number of 
view fields (n)
Number of 
tested cells 
(min-max)
Distance 
passed (µm)
Trajectory 
length (µm)
Average speed 
of trajectory 
pass (µm/h)
Angle of cell 
population 
movement (°)
Control 
without 
exposure
47 8 12–15 291.75±31.07 1423.25±105.21 30.10±2.23 324.50±18.30
TGFβ
1
 
(10 ng/ml)
47 8 15–18 136.0±7.32 676.0±20.46 14.32±0.42 234.0±3.85
р, vs Control 0.042 0.009 0.009 0.051
IL-10 
(1 ng/ml)
47 8 11–15 44.45±1.84 224.25±10.76 10.45±0.52 254.25±11.01
р, vs Control 0.004 0.001 0.002 0.066
VEGF 
(50 ng/ml) 
47 6 10–17 176.5±32.54 881.4±88.90 18.7±1.89 289.1±35.55
р, vs Control 0.068 0.005 0.006 0.067
Figure 2. Centring the 
trajectories of movement of 
immature dCs in the pres-
ence of skin melanoma 
cells line #894. A – under 
standard conditions, 
B – in the presence of 
TGFβ1 (10 ng/ml), 
C – in the presence 
of IL-10 (1 ng/ml), 
d – in the presence of 
VEGF (50 ng/ml)
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showed a decrease in the movement activity of the 
DCs and an increase in chaotic state of the motion 
(Figures 3, 4). The estimation of the motion pattern 
of the DCs in a two-dimensional coordinate system, 
taking into account the number of cells that overcome 
this distance at a certain point in time, made it pos-
sible to establish that all the studied ISFs had a similar 
inhibitory effect on the motility of DCs, the effect of 
IL-10 was maximal (Figure 4).
Discussion
DCs, as highly specialised antigen-presenting cells, 
are effective inducers of T-lymphocyte mediated re-
sponses and traditionally are considered as a decisive 
component in the implementation of an antitumor im-
mune response [15]. DCs are found in various tumors, 
such as breast cancer, colorectal cancer, ovarian, lung, 
stomach, bladder cancer, etc. It is not surprising that 
in numerous publications of recent decades there are 
conflicting evidences of the association of tumor DCs 
infiltration with a positive or negative prognosis of the 
disease course and stage.
DCs in tumors are often characterized by a phe-
notype with a weak expression of co-stimulatory 
molecules, ineffective cross-presentation of antigens, 
as well as by the expression of regulatory molecules 
and receptors that often promote the development of 
immunosuppression [16, 17]. In animal models, it was 
shown that the type, phenotype and amount of DCs 
present in the tumor are dynamic during the tumor 
growth and are associated with the stage of the dis-
ease. J. Krempski et al. (2011) on the model of ovary 
cancer ID8 in mice demonstrated that the increase 
in tumor size resulted in a significant increase in the 
number of DCs in the tumor. Here, almost all DCs 
had immunosuppressive potential, and the number 
of T-lymphocytes infiltrating the tumor significantly 
decreased [18].
Tumor cells and other components of the tumor 
microenvironment synthesize and release factors that 
are capable of inhibiting or altering the maturation and 
activity of DCs. Besides, for a successful presentation 
of antigens, a high migration speed and a low degree 
of adhesion are necessary, and the change in these 
parameters must have a certain directionality during 
the DCs maturation process [19, 20].
A.J. Michielsen et al. (2011) showed that the condi-
tioned medium of tissue explants of human colorectal 
cancer had a high content of VEGF and chemokines 
CCL2, CXCL1, CXCL5. Pre-incubation of DCs in 
this medium in vitro led to blockade of their matura-
tion [21]. Moreover, as it turned out, in addition to 
the biochemical effects the ISFs produced by tumor 
cells influence the biophysical properties of the DCs 
preventing their effective migration. Most protocols 
of antitumor DCs immunotherapy are based on the 
Figure 3. Graphical mapping of directions of 
movement of immature dCs and quantita-
tive evaluation of the preferred direction of 
movement in the co-cultivation system with 
skin melanoma cells line #894. A – under 
standard conditions, 
B– in the presence of TGFβ1 (10 ng/ml), 
C – in the presence of IL-10 (1 ng/ml), 
d – in the presence of VEGF (50 ng/ml)
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Figure 4. Graphical representation of 2d percentage distribution of immature dCs in movement in the co-cultivation system with skin 
melanoma cells line #894. A – under standard conditions, B – in the presence of TGFβ1 (10 ng/ml), C – in the presence 
of IL-10 (1 ng/ml), d – in the presence of VEGF (50 ng/ml). Red line ■ – 15 % of dCs, orange line ■ – 30 % of dCs, 
yellow line ■ – 50 % of dCs, green line ■ – 100 % of dCs
activation of DCs in vitro by loading with antigens 
contained in autologous and / or allogeneic tumor cells 
lysates. The activation of DCs is associated including 
the enhancement of expression of intracellular and 
surface molecules that provide DCs movability and 
ability to migrate. However, these processes are de-
pendent on the microenvironment and can be blocked 
or modified by specific ISFs synthesised into the 
surrounding microenvironment, which may be the 
cause of the low efficacy of DCs-vaccine therapy in 
individual patients. 
In this study, an in vitro model was created which 
allowed estimation of the influence of the ISFs pro-
duced by human skin melanoma cells on the efficacy of 
migration and activation of maturating DCs. It turned 
out that the most prominent inhibitory effect on the 
movability of maturing DCs had IL-10, and there was 
an inverse relationship between the production of IL-
10 by skin melanoma cells and the speed of movement 
of the DCs (p<0.05) (Tables 2, 4). X. Xu et al. (2017) 
demonstrated the influence of IL-10 on biophysical 
characteristics of DCs, such as deformability, osmotic 
resistance and electrophoretic mobility [11]. It was 
found that IL-10 critically affected these parameters, 
contributing to their reduction. The electrophoretic 
mobility of DCs was associated with the presence 
of negative charges on their surface membrane. It 
has be established that the number of these charges 
continuously increases during the differentiation proc-
ess (maturation and activation) of the DCs, which is 
directly linked with their movability [22]. Decrease 
of these charges on the surface of the cell membrane 
leads to an increase in the adhesion forces of the DCs 
to the components of the tumor microenvironment, and 
limits the motility of the DCs. The ability to change 
the shape of a cell is important in the migration proc-
ess when passing a wall of blood or lymphatic vessel 
through the connections between the cells and the 
complex extracellular matrix. Studies of Z. Zeng et al. 
(2006) demonstrated that DCs showed a high capacity 
for deformation at different stages of differentiation, 
starting from a monocytic population [23]. Defects of 
properties to change the shape of cells that arise under 
the influence of IL-10 can contribute to the weaken-
ing of their migration, which can be considered as 
one of the elements of the phenomenon of «immune 
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escape» (evasion from the immune control) of tumor 
cells [9].
In our study, it was found that TGFβ1 and VEGF 
had a similar effect on DCs migration, blocking their 
movability. Differences between control samples and 
samples with increased number of these ISFs were 
statistically significant (p<0.05) in two parameters: 
trajectory length and average speed of trajectory 
pass (Table 4). Study done by Z.Q. Hu et al. (2016), 
identified that VEGF affected the biophysical 
properties of such structures of the DCs as the outer 
cytoplasmic membrane and the cytoskeleton, which 
led to immobilization of the DCs and disrupted their 
ability to antigen presentation [24]. It was suggested 
that the electrical potential of the cell membrane was 
changed by VEGF, thus influencing the effectiveness 
of immunological synapses formed by the DCs.
L.K. Spary et al. (2014) on the in vitro model of 
tumor and stromal cells of prostate cancer showed 
that DCs cultured in the presence of TGFβ
1 
and se-
creted by stromal cellular elements lost expression of 
CD209, retained expression of СD14 and were unable 
to present antigens for T-lymphocytes [24]. These 
experiments demonstrated the role of the immunosup-
pressive microenvironment in the blockade of normal 
DCs maturation.
We obtained data on the inverse dependence of the 
movability of the DCs on the presence in the micro-
environment of a number of growth factors, such as 
EGF, FGF, HGF (Table 2). In the literature, there are 
data on the effect of these factors on the mobility of 
eukaryotic cells [25, 26]. It is known that HGF changes 
the direction of DCs differentiation, contributing to the 
formation of a tolerogenic immunophenotype, but the 
mechanism of action of this factor on the DCs has not 
been studied sufficiently yet [27]. In addition, it was 
shown that under the influence of HGF, the adhesion 
of DCs to laminin was increased [28]. In our study, an 
inverse relationship was found between the production 
of FasL by skin melanoma cells and the speed of DCs 
movement in the studied system.
Among the numerous publications devoted to the 
analysis of elements of the tumor microenvironment 
that hamper the formation of the immunophenotype 
of the DCs, which is productive for the formation of 
an effective immune response, there are data on the 
presence in the tumor stroma of an increased amount 
VEGF, TGFβ1, IL-10, prostaglandin E2, phosphati-
dylserine, ligand of cytotoxic T-lymphocytes receptor 
and natural killers MICA, Fas receptor and its ligand 
FasL [29]. All these molecules are able to inhibit the 
interaction of DCs and T-lymphocytes.
Thus, it can be assumed, why in a comparative in 
vivo study of migration of mature and immature DCs 
labelled with radioactive iodine, when DCs vaccines 
were administered to patients with disseminated forms 
of skin melanoma, a very low number (<1%) of the 
DCs reached lymph nodes after intradermal adminis-
tration [30].
Conclusions
DCs are a complex diversified cellular population 
with the goal to recognize, capture and deliver the 
foreign antigens to T-lymphocytes. This predetermines 
the ability of DCs to actively migrate inside a complex 
three-dimensional microenvironment, populated by 
other cellular elements. The study of the migration 
properties of the DCs using the in vitro model of 
co-cultivation with human melanoma cells under the 
influence of factors of a tumor microenvironment 
showed the following:
1. There is an inverse correlation between the 
quantitative content of TGFβ
1
, IL-10, IL-18, VEGF-A, 
EGF, FGF, HGF, sFASL in the supernatants of skin 
melanoma cell lines and the average speed of the DCs 
movement, determined in analytical system Cell-IQ, 
(p<0.01).
2. There is an inverse high strength correlation 
between the angle of movement of the DCs popula-
tion and the expression of antigens (Melan A, tyrosi-
nase, families MAGE, BAGE, NY-ESO-1) by skin 
melanoma cells, (p<0.05).
3. When exposed to IL-10 (1 ng/ml), TGFβ1 (10 ng/
ml), VEGF-A (50 ng/ml), the length of the trajectory 
and the average speed of trajectory pass of the DCs 
are decreased (p<0.05).
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